Riccardo Ponzone
- Cancer Research top 1%
- Breast Cancer Treatment Studies 40
- Oncology top 2%
- HER2/EGFR in Cancer Research 16
- Cancer Risks and Factors 15
-
- Breast Lesions and Carcinomas 20
- Genetics top 5%
- Estrogen and related hormone effects 27
- BRCA gene mutations in cancer 10
-
- Breast Implant and Reconstruction 19
-
- Menopause: Health Impacts and Treatments 11
Riccardo Ponzone
120 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 1.2k
- Oncology 1.2k
- Pathology and Forensic Medicine 626
- Genetics 336
- Radiology, Nuclear Medicine and Imaging 646
Countries citing papers authored by Riccardo Ponzone
This map shows the geographic impact of Riccardo Ponzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riccardo Ponzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riccardo Ponzone more than expected).
Fields of papers citing papers by Riccardo Ponzone
This network shows the impact of papers produced by Riccardo Ponzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riccardo Ponzone. The network helps show where Riccardo Ponzone may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Riccardo Ponzone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 1 | |
| 5 | BRCA変異キャリアにおける臨床的および機器的サーベイランスおよび予防的手術のクオリティオブライフに対する満足度および影響【JST・京大機械翻訳】 | 2018 | 1 |
| 6 | 2018 | 1 | |
| 7 | 2016 | 28 | |
| 8 | 2016 | 6 | |
| 9 | miR-148b is a major coordinator in a relapse-associated miR signature in breast tumors | 2011 | 2 |
| 10 | 2010 | 19 | |
| 11 | 2010 | 102 | |
| 12 | 2007 | 4 | |
| 13 | 2006 | 25 | |
| 14 | 2004 | 11 | |
| 15 | 2003 | 41 | |
| 16 | 2002 | 41 | |
| 17 | 2001 | 6 | |
| 18 | 1996 | 47 | |
| 19 | 1995 | 51 | |
| 20 | Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer. | 1994 | 77 |
About Riccardo Ponzone
Riccardo Ponzone is a scholar working on Cancer Research, Oncology and Reproductive Medicine, having authored 125 papers that have together received 3.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (40 papers), Estrogen and related hormone effects (27 papers), Breast Lesions and Carcinomas (20 papers), Breast Implant and Reconstruction (19 papers), HER2/EGFR in Cancer Research (16 papers), Cancer Risks and Factors (15 papers), Menopause: Health Impacts and Treatments (11 papers) and BRCA gene mutations in cancer (10 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.2k citations) and Pathology and Forensic Medicine (626 citations). Riccardo Ponzone has collaborated with scholars based in Italy, Canada and United States. Frequent co-authors include P Sismondi, Nicoletta Biglia, Riccardo Roagna, Furio Maggiorotto, Eleftherios P. Diamandis, Filippo Montemurro, Laura Martincich, M Giai, Franziska Kubatzki and Massimo Aglietta. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.